Baxter International: Insider and Fund Stock Sales in Third Quarter

Insiders are generally long-term investors due to restriction in making short-term profits. In contrast, wealth management institutions always have short-term investment. Wall St. Watchdog reveals information regarding the insiders and institutions which recently decreased stock shares of Baxter International Inc. (NYSE:BAX).

SEC data indicate these insiders have sold Baxter International Inc.��s stock since 06/30/2011:

• Parkinson Robert L Jr: act as Chairman of the Board & CEO. On 10/26/2011, sold 324,345 shares, worth $17,900,600.
• Parkinson Robert L Jr: act as Chairman of the Board & CEO(Click HERE for the list of stocks that their CEOs have bought). On 10/27/2011, sold 275,655 shares, worth $15,252,000.
• Davis Robert M: act as Corporate Vice President. On 07/25/2011, sold 101,000 shares, worth $6,227,700.
• Forsyth John D: act as Director. On 07/28/2011, sold 11,610 shares, worth $689,800.

SEC data indicate that these institutions significantly reduced their stock shares of Baxter International Inc. in Q3 2011:

• PAULSON MANAGEMENT LLC: On 06/30/2011, held 6,220,500 shares, worth $349,218,870. On 09/30/2011, held 0 shares.
• ALYESKA INVESTMENT GROUP, L.P.: On 06/30/2011, held 911,195 shares, worth $51,154,487. On 09/30/2011, held 0 shares.
• PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO: On 06/30/2011, held 794,313 shares, worth $44,592,732. On 09/30/2011, held 0 shares.
• TURNER INVESTMENT PARTNERS INC: On 06/30/2011, held 773,963 shares, worth $43,450,283. On 09/30/2011, held 0 shares.
• HUSSMAN ECONOMETRICS ADVISORS, INC.: On 06/30/2011, held 400,000 shares, worth $22,456,000. On 09/30/2011, held 0 shares.

About the company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immun! e disord ers, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

Competitors to Watch: Covidien plc (NYSE:COV), C.R. Bard, Inc. (NYSE:BCR), ICU Medical, Incorporated (NASDAQ:ICUI), Teleflex Incorporated (NYSE:TFX), Hospira, Inc. (NYSE:HSP), CryoLife, Inc. (NYSE:CRY), Becton, Dickinson and Co. (NYSE:BDX), CareFusion Corporation (NYSE:CFN), Haemonetics Corporation (NYSE:HAE), and NxStage Medical, Inc. (NASDAQ:NXTM).